Natural history of cervicovaginal papillomavirus infection in young women

New England Journal of Medicine

Volumn 338, Issue 7, 1998, Pages 423-428

  Ho, Gloria Y F ^a   Bierman, Robert ^b   Beardsley, Leah ^b   Chang, Chee J ^a   Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONDYLOMA; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMA VIRUS; PRIORITY JOURNAL; RISK FACTOR; VIRUS DETECTION;

ADOLESCENTS; ADOLESCENTS, FEMALE; AGE FACTORS; AMERICAS; BIOLOGY; CROSS SECTIONAL ANALYSIS; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; EPIDEMIOLOGY; HEALTH; HPV; NEW JERSEY; NORTH AMERICA; NORTHERN AMERICA; POPULATION; POPULATION CHARACTERISTICS; PUBLIC HEALTH; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK FACTORS; UNITED STATES; VIRAL DISEASES; WOMEN; YOUTH--WOMEN;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; INCIDENCE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL DISEASES;

EID: 0032510076     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199802123380703     Document Type: Article

References (35)

1. Burk RD, Ho GYF, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infrct Dis 1996;174:679-89.
2. Evander M, Edlund K, Gustafsson A, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995;171:1026-30.
3. Karlsson R, Jonsson M, Edatmd K, et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 1995;22:119-27.
4. Fairley CK, Chen S, Ugoni A, Tabrizi SN, Forties A, Garland SM. Human papillomavirus infection and its relationship to recent and distant sexual partners. Obstet Gynecol 1994;84:755-9.
5. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-bascd method. JAMA 1991;265:472-7.
6. Ho GYF, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
7. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
8. Bosch FX, Munoz N, De Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992;52:750-8.
9. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991;83: 997-1003.
10. Brisson J, Bairati I, Morin C, et al. Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J Infect Dis 1996;173:794-9.
11. Hinchliffe SA, van Velzen D, Korporaal H, Kok PL, Boon ME. Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br J Cancer 1995;72:943-5.
12. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
13. Moscicki A-B, Palcfsky JM, Gonzales J, Smith G, Schoolnik GK. Colposcopic and histologic findings and human papillomavirus (HPV) DNA test variability in young women positive for HPV DNA. J Infect Dis 1992; 166:951-7.
14. Roscnfeld WD, Rose E, Vermund SH, Schreiber K, Burk RD. Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescents. J Pediatr 1992;121:307-11.
15. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective: International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
16. Goldberg GL, Vermund SH, Schiffman MH, Ritter DB, Spitzer C, Burk RD. Comparison of cytobrush and cervicovaginal lavage sampling methods for the detection of genital human papillomavirus. Am J Obstet Gynecol 1989;161:1669-72.
17. Burk RD, Kadish AS, Calderin S, Romney SL. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol 1986;154:982-9.
18. Liang K-Y, Zegcr SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
19. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-60.
20. SAS/STAT user's guide, version 6, 4th ed. Vol. 2. Cary, N.C.: SAS Institute, 1989.
21. Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics 1982;38:29-41.
22. Thompson WD. Statistical analysis of case-control studies. Epidemiol Rev 1994;16:33-50.
23. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996;23:333-41.
24. Moscicki A-B, Palcfsky J, Gonzales J, Schoolnik GK. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors. Pediatr Res 1990;28:507-13.
25. Romney SL, Ho GYH, Palan PR, et al. Effects of β-carotcnc and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 1997;65:483-92.
26. Hsing AW, Schiffman M, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;170:498.
27. de Villiers E-M, Wagner D, Schneider A, et al. Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study. Gynecol Oncol 1992;44:33-9.
28. Brinton LA, Fraumeni JF Jr. Epidemiology of uterine cervical cancer J Chronic Dis 1986;39:1051-65.
29. Vermund SH, Kelley KF, Klein RS, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991;165:392-400.
30. Maiman M, Fruchter RG. Cervical neoplasia and the human immunodeficiency virus. In: Rubin SC, Hoskins WJ, eds. Cervical cancer and preinvasive neoplasia. Philadelphia: Lippincott-Raven, 1996:405-16.
31. Richart RM, Barnm BA. A follow up study of patients with cervical dysplasia. Am J Obstct Gynecol 1969;105:386-93.
32. Nasiell K, Roger V, Nasiell M Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-9.
33. Daling JR, Madeleine MM, McKnight B, et al. The relationship of human papillomavirus-relatcd cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkcrs Prev 1996;5:541-8.
34. Winkelstein W Jr. Smoking and cervical cancer - current status: a review. Am J Epidemiol 1990;131:945-57
35. Nasiell K, Nasiell M, Vaclavinkova V. Behavior of moderate cervical dysplasia during long term follow up. Obstet Gynecol 1983;61:609-14.